Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An Oxford-based international online project to tackle antibiotic resistance has picked up a national health research award.

Dr Philip Fowler

BashTheBug, an initiative funded by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), brings together volunteers from all over the world to take part in the online research study, which has looked at hundreds of thousands of tuberculosis samples.

On Monday (4 September), the NIHR announced that BashTheBug had won the online community category in its Let’s Get Digital competition.

On learning of the news, Dr Philip Fowler, Senior Researcher at the NIHR Oxford BRC who leads the project, said: “Thank you NIHR! This award recognises all the hard work done by our more than 6,000 citizen scientists through the Zooniverse online community.

“In five months they’ve classified almost 350,000 images of M. tuberculosis growing on a range of antibiotics which help us improve the diagnosis of TB.”

Dr Fowler, who is based at the John Radcliffe Hospital in Oxford, is a computational biophysicist working in infectious diseases.

The NIHR praised BashTheBugwhich was only launched in April 2017, for its engaging and creatively designed citizen science project and for keeping the public and participants regularly updated via a blog and Twitter.

BashTheBug was one of five shortlisted entries, all of which were reviewed by an expert judging panel and subject to a public vote.

The panel liked the way this community is brought together by people actually taking part in a research study, and was impressed with its reach and the number of interactive ways to get involved.

Expert judge Verity Cardenas, Europe, Middle East and Africa (EMEA) Programme Manager at Google, said: "I really like the active engagement of users on the website with a step by step understanding of what is required of a volunteer. This gives me a feel for what it is like to be involved in clinical research."

The Let’s get Digital competition aims to demonstrate the interesting digital methods that people across the NIHR can use to promote research, and reward those that are already doing it successfully.

The organisers are looking “to capture why NIHR research is important and exciting” and to show “how vital it is to the development of new and better treatments in the NHS”.

The competition, which was brand new for this year, aimed to promote and recognise the ways people funded and supported by the NIHR can ‘get digital’ with their research, whilst raising awareness of research at the same time. Entries were invited across five categories - video, photo, infographic, online community and website.

The 165 entries to the competition, and 2,251 public votes, demonstrate the value of digital when it comes to engaging with research. You can still get involved in the campaign by promoting BashTheBug and the other winning entries as excellent examples of making research accessible in innovative, digital formats. All the shortlisted and winning entries can be found here.   



The NIHR Oxford Biomedical Research Centre (OxBRC) is based at the Oxford University Hospitals NHS Foundation Trust and run in partnership with the University of Oxford, funded by the National Institute for Health Research (NIHR).

The Oxford Academic Health Science Network (AHSN) is licensed by NHS England. It brings together universities, industry and the NHS to improve prosperity in our region through rapid channel innovation adoption.

Oxford University Innovation is the research and technology commercialisation company of the University of Oxford. It provides access to technology from Oxford researchers through intellectual property licensing, spinout company formation and material sales, and to academic expertise through Oxford University Consulting.

The Oxford Academic Health Science Centre (Oxford AHSC) coordinates clinical and academic excellence within Oxford University, Oxford Brookes University, Oxford Health NHS Foundation Trust and Oxford University Hospitals NHS Foundation Trust.



Similar stories

Reducing fat in the diabetic heart could improve recovery from heart attack

New research from the Department of Physiology, Anatomy and Genetics has shown that in type 2 diabetes an overload of lipids reduces the heart’s ability to generate energy during a heart attack, decreasing chances of recovery.

Brain cortex may regulate the need for sleep

Why we sleep, and the processes behind sleep, are amongst the most interesting questions in modern neuroscience.

New data show rise in hospital admissions for unvaccinated pregnant women

The Chief Midwifery Officer for England will urge expectant mums to have their COVID-19 vaccination as soon as possible. This follows a worrying rise in unvaccinated women being admitted to hospital with severe COVID-19, and evidence that the Delta variant poses a significantly greater risk than all previous strains.

Cooking with coal or wood associated with increased risk of major eye diseases

A study involving nearly half a million people in China reveals a clear link between cooking with wood or coal, and an increased risk of major eye diseases that can lead to blindness, according to a report published today in PLOS Medicine.

Oxford's COVID African Innovation Seed Fund announced

Five graduate students currently studying at Oxford, including two Medical Sciences students, have been awarded £1,000 grants from the Vice Chancellor’s COVID-19 African Innovation Seed Fund for entrepreneurial projects aimed at addressing global challenges stemming from the pandemic.

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.